5-(2,5-dimethoxyphenyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

CILNIDIPINE, 98%, 10g

Acetyl-L-aspartic acid a-methyl ester, 98.0%, 10g

2-(Benzoylamino)-5,6-dihydro-4H-cyclopenta[d][1,3]thiazole-4-carboxylic acid, 95.0%, 500mg

2',4'-Dimethoxyacetoacetanilide>95.0%(N)500g

CYCLOBUTANAMINE, 3-(3,4-DIMETHOXYPHENOXY)-, HCL (1:1), TRANS-, 95.0%, 1g

2-Nitrophenyl beta-D-Galactopyranoside [Substrate for beta-D-Galactosidase]>98.0%(HPLC)1g

1,2-Diphenylpyrazolidine-3,5-dione, 95.0%, 25g

1-Cyclohexyl-2-pyrrolidone, 98.0%, 500ml

trans-2-Hexenal>97.0%(GC)500mL

1,4-Diaminoanthraquinone>97.0%(N)25g

2-[1-Amino-2-(3-chloro-phenyl)-ethylidene]-malononitrile, 95.0%, 5g

Ethyl 10-bromodecanoate, 96.0%, 5g